ampelopsin has been researched along with Cicatrix, Hypertrophic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pang, Z; Ye, X; Zhu, N | 1 |
1 other study(ies) available for ampelopsin and Cicatrix, Hypertrophic
| Article | Year |
|---|---|
Dihydromyricetin attenuates hypertrophic scar formation by targeting activin receptor-like kinase 5.
Topics: Adolescent; Adult; Animals; Biocatalysis; Cell Proliferation; Cicatrix, Hypertrophic; Female; Fibroblasts; Flavonols; Humans; Male; Mice; Mice, Inbred BALB C; Molecular Docking Simulation; Molecular Targeted Therapy; Phosphorylation; Protein Conformation; Receptor, Transforming Growth Factor-beta Type I; Smad2 Protein; Smad3 Protein; Young Adult | 2019 |